Ken Galbraith, Chair and CEO of Zymeworks, shares insights on biotech leadership, developing treatments for challenging cancers, and the importance of resilience in the industry. He discusses empowering talent, innovative biologic structures, and seeking advice for better decision-making. A must-listen for aspiring biotech leaders and professionals.